Utility of a new strain for the control of hepatic and intestinal inflammation - Banco de Patentes

New strain for the treatment and/or prevention of pathologies with hepatic or intestinal inflammation, especially in patients with cirrhosis. Besides its use as a probiotic, it can restore intestinal dysbiosis associated with clinically relevant complications or prevent non-selective eradication of the microbiota and the emergence of resistance, the main problems associated with the increasing use of antibiotics.